Measurement properties of the AUA symptom score: A methodological clarification

British Journal of Urology

Volumn 77, Issue 2, 1996, Pages 175-180

  Lawrence, K ^a  

^a McMastcr Universilji ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; HUMAN; MEASUREMENT; METHODOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SYMPTOM; UROLOGY;

EID: 0030065465     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.08651.x     Document Type: Review

References (26)

1. Spilkcr K. Quality of Life Assessments in (.'linical Trials. New York: Raven Press, 1990
2. [enkinson C. Measuring Healtli: Questionnaire Design anil Application. London: UCL Press. 1994
3. Barry MJ. l-'owler FJ. ()'Le;iry M P cl al. The American l rological Association symptom index l'or benign prostatic hyperphisia. U roi 1992: 148: l 549-57
4. Barry MJ. Cockett AT. Holtgrewe HL et ni. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures ol the severity of benign prostatic hyperplasia. U ml 1993: 150: 3 5 1-8
5. Barry MJ. Fowler FJ, OT.eary M P et al. Correlation of the American Urological Association symptom index with selladministered versions ol the Madsen-Iverson, Boyarsky and Maine Medical Assessment programme symptom indexes. U ml 1992: 148: 1558-63
6. (Barry MJ. (ïirman (.'). O'Leary MP et ni. L sing repeated measures of symptom score, urollowmetry and prostate specific antigen in the clinical management of prostate disease. I!ml I99r 15: 99-103
7. Fowler F|. Barry ,V1J. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. Eur Urol 1995: 24 (suppl 1): 24-7
8. IS Sagnier I'P. Richard F. Botto H er til. Adaptation and validation in the French language of the international score of symptoms for BPH. Prog Urol 1994: 4: 532-8
9. Barry MJ. Chang YuChiao. U'alker-Corkery B et al. How much change in the Al'A symptom index is perceptible to patients- J 1995; 155 (suppl): 275A
10. Chancellor MB, Rivas DA. American lirological Association Symptom Index for women with voiding symptoms: lack of index specificity for BPH. J U ml 1993: 150: 1706-9
11. Chai TC. Belville WD. McGuire Ff. Nyquist L. Specilicity of the Al'A Voiding Symptom Index: Comparison of unselected and selected samples of both sexes. J Urol 1995: 150: 1 710-1 5
12. I.epor 11. Machi Cl. Comparison of AUA symptom index in unselected males and females between fifty-live and seventynine years of age. Urology 1995: 42: 36-41
13. Yalla SV. Sullivan MP. Lecamwasam HS et al. Correlation of Al'A symptom index with obstructive and nonobstructive prostatism. J I'rol 1995: 155: 674-80
14. Sirls IT. Jay J. Kirkemo A. Does the Al'A symptom score correlate with urodynamic obstruction- J Urol 1995: 155: 275A
15. Chappie C. Woo 1111. Rosario DJ. Fleet C. Correlation of the Il'SS symptom score with Undings on video pressure-flow studies. J U ml 1995: 155: 275A
16. Mat/kin H. Greenstein A. Prager-Geller T. Brat J,. AUA symptom score -comparison of patient responses with the analysis of 24 hour home llowmetrv. J I'ro/ 1995: 155: 598A
17. Chancellor MB. Rivas DA. Keeley MA. Camélia Lotli I.C,. Similarity of the American Urologieal Association Symptom Index among men with benign prostatic hyperplasia (BPH I. urethral obstruction not due to BPH and detrusor hyperrellexia without outlet obstruction. Kr Urol 1994: 74: 200-5
18. Ciuyatt CH. Kirshner B. Jaeschke R. Measuring health status: what are the necessary measurement properties. J Clin l'.pid 1992: 45: 1341-5
19. Streiner DL. Norman GR. Validity. Ch 10. In Health measurement scales: a practical i]iiide to their development and use. New York: Oxford University Press. 1989
20. Department of Veterans Affairs Cooperative Study of Transurethral Resection of BPH. A comparison of quality of life with patient reported symptoms and objective Undings in men with BPH. J I'rol 1993: 150: 1696-1700
21. Bosch (L. Groen J, Schröder F. Treatment of benign prostatic hyperplasia by transurethral ultrasound guided laser-induced prostatectomy:effects on urodynamic parameters and symptoms. LJroloaii 1994: 44: 507-10
22. Keoghane S. Cranston D. Lawrence K. Doll H. Fellows G. Smith G. 'Fhe Oxford laser prostate trial: a randomised controlled trial of contact vaporisation of the prostate versus TURP. / L'rol 1995: 155: 2 30A
23. Slaa F. Mooibroek ]]. Reijke TM et til. Faser treatment of the prostate using the urolase fiber: the Dutch experience. J Urol 1995: 153: 230A
24. Streiner DL, Norman GR. Reliability. In: Health measurement scales: a practical guide to their development and use. New York: Oxford University Press. 1989
25. Guess HA, Chute CG. Garraway M et al. Similar levels of urological symptoms have similar impact on Scottish and American men. / Urol 1993; 150: 1701-5
26. K. Lawrence, MSc, MFPHM, Visiting Research Fellow, Department of Clinical Epidemiology and Biostatistics (CH-74), McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.